|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: POLYDEX PHARMACEUTICALS LTD/BAHAMAS, 10-Q, 2000-12-14 |
Next: CENTRAL CAPITAL VENTURE CORP, 10QSB, 2000-12-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JAN-31-2001
<PERIOD-START> FEB-01-2000
<PERIOD-END> OCT-31-2000
<CASH> 476,282
<SECURITIES> 0
<RECEIVABLES> 1,472,488
<ALLOWANCES> 16,969
<INVENTORY> 2,000,610
<CURRENT-ASSETS> 4,043,500
<PP&E> 10,128,850
<DEPRECIATION> 5,048,734
<TOTAL-ASSETS> 11,304,634
<CURRENT-LIABILITIES> 2,319,374
<BONDS> 942,028
0
15,010
<COMMON> 50,350
<OTHER-SE> 23,169,085
<TOTAL-LIABILITY-AND-EQUITY> 11,304,634
<SALES> 10,552,501
<TOTAL-REVENUES> 10,734,901
<CGS> 7,746,123
<TOTAL-COSTS> 7,746,123
<OTHER-EXPENSES> 2,510,249
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 224,703
<INCOME-PRETAX> 279,360
<INCOME-TAX> 291,739
<INCOME-CONTINUING> (12,379)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (12,379)
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|